Trial intelligence / Profile preview

Recombinant HCG in infertile women undergoing IVF

IRCT2015012020736N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Dec 2013
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of recombinant human chorionic gonadotrophin in female infertility, sponsored by Tehran University of Medical Sciences. Started Dec 2013; status: completed.

02

Drugs

recombinant human chorionic gonadotrophin
03

Conditions

female infertility

Beyond the preview

Go deeper on IRCT2015012020736N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015012020736N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call